The following new grants were awarded to JCCC members, announced in May 2012:
Principal Investigator:
Bensinger, Steven
Sponsor Name: NIH/National Institute Of Allergy And Infectious Diseases
Award Title: Determining the Impact of SREBP on Adaptive Immunity
Principal Investigator: Chmielowski, Bartosz
Sponsor Name: Bristol-Myers Squibb Company
Award Title: A Randomized Double-Blind Phase III Study of Ipilimumab Administered at 3 Mg/Kg Versus at 10 Mg /Kg in Subjects with Previously Treated or Untreated Unresectable Or Metastatic Melanoma
Principal Investigator: Goldman, Jonathan
Sponsor Name: Bristol-Myers Squibb Company
Award Title: A Multi-Arm Phase I Study of BMS-936558 in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Or Carboplatin/Paclitaxel in Subjects with Treatment-Naive Stage Iiib/Iv Non-Small Cell Lung Cancer (NSCLC)
Principal Investigator: Heber, David
Sponsor Name: Life Bridge International
Award Title: Effects of Xylooligosarcharide on Composition of the Human Colonic Microflora
Principal Investigator: Pothoulakis, Charalabos
Sponsor Name: Optimer Pharmaceuticals, Inc.
Award Title: Effect of Optimer Compunds in Toxin-A Mediated Inflammaotry Responses in Mouse Lleal Loops in vivo
Principal Investigator: Schiller, Gary
Sponsor Name: Bristol-Myers Squibb Company
Award Title: A Phase 3, Randomized, Open Label Trial of Lenalidomide / Dexamethasone with or Without Elotuzumab in Relapsed or Refractory Multiple Myeloma
Principal Investigator: Schiller, Gary
Sponsor Name: Bristol-Myers Squibb Company
Award Title: A Phase 2, Randomized Study of Bortezomib / Dexamethasone with or Without Elotuzumab in Subjects with Relapsed / Refractory Multiple Myeloma
Principal Investigator: Segura, Tatiana
Sponsor Name: NIH/Center For Scientific Review
Award Title: Vegf Ligand Presentation and Therapeutic Angiogenesis
Principal Investigator: Wu, Anna
Sponsor Name: NIH/Center For Scientific Review
Award Title: Antipsca A11 Minibody for Diagnosis and Therapy of Prostate Cancer (Knowles)